His main research concerns Virology, Catheter, Antimicrobial, Intensive care medicine and Urinary system. He has included themes like Infection control and Coronavirus disease 2019 in his Virology study. His Catheter research incorporates elements of Pyuria, Hemocytometer, Asymptomatic, Coating and Biomedical engineering.
His Intensive care medicine research is multidisciplinary, relying on both Bacteriuria, Antibiotic resistance, Urinary catheterization and Drug resistance. While the research belongs to areas of Antibiotic resistance, Paul A. Tambyah spends his time largely on the problem of Methicillin-resistant Staphylococcus aureus, intersecting his research to questions surrounding Antibiotics. He has researched Urinary system in several fields, including Guideline and Prospective cohort study, Surgery.
Virology, Internal medicine, Immunology, Intensive care medicine and Coronavirus disease 2019 are his primary areas of study. His research on Virology frequently connects to adjacent areas such as Pandemic. His biological study spans a wide range of topics, including Gastroenterology, Antibiotics and Surgery.
His research in Surgery intersects with topics in Staphylococcal infections and Urinary system. He does research in Intensive care medicine, focusing on Infection control specifically. His Infection control study incorporates themes from Antibiotic resistance and Isolation.
His primary areas of study are Coronavirus disease 2019, Internal medicine, Severe acute respiratory syndrome coronavirus 2, Immunology and Virology. His Coronavirus disease 2019 study deals with Outbreak intersecting with Isolation. His research integrates issues of Gastroenterology and Antibiotics in his study of Internal medicine.
His study in Antibiotics is interdisciplinary in nature, drawing from both Toxicity and Intensive care medicine. His Asymptomatic research extends to Immunology, which is thematically connected. The study incorporates disciplines such as Epitope, Common cold, Coronavirus and Pneumonia in addition to Virology.
His scientific interests lie mostly in Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Internal medicine, Virology and Serology. Coronavirus disease 2019 is a primary field of his research addressed under Disease. His Internal medicine research focuses on Stenosis, Mortality rate, Embolism, Incidence and Complication.
His work deals with themes such as Epitope, Common cold and Pneumonia, which intersect with Virology. The concepts of his Serology study are interwoven with issues in Gastroenterology, Viral culture, Virus, Viral pneumonia and Immunotherapy. His Pandemic research includes elements of Young adult and Tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Nina Le Bert;Anthony T Tan;Kamini Kunasegaran;Christine Y L Tham.
Engineering out the risk for infection with urinary catheters.
Dennis G. Maki;Paul A. Tambyah.
Emerging Infectious Diseases (2001)
Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients.
Paul A. Tambyah;Dennis G. Maki.
JAMA Internal Medicine (2000)
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
Patrick N. A. Harris;Patrick N. A. Harris;Patrick N. A. Harris;Paul A. Tambyah;David C. Lye;David C. Lye;David C. Lye;Yin Mo.
European and Asian guidelines on management and prevention of catheter-associated urinary tract infections.
Peter Tenke;Bela Kovacs;Truls E. Bjerklund Johansen;Tetsuro Matsumoto.
International Journal of Antimicrobial Agents (2008)
The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: a Perspective from Asia
James S. Molton;Paul A. Tambyah;Paul A. Tambyah;Brenda S. P. Ang;Moi Lin Ling.
Clinical Infectious Diseases (2013)
Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
Ann Versporten;Peter Zarb;Isabelle Caniaux;Marie Françoise Gros.
The Lancet Global Health (2018)
The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care.
Paul A Tambyah;Valerie Knasinski;Dennis G Maki.
Infection Control and Hospital Epidemiology (2002)
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
Hosam M. Zowawi;Patrick N. A. Harris;Matthew J. Roberts;Paul A. Tambyah.
Nature Reviews Urology (2015)
A prospective study of pathogenesis of catheter-associated urinary tract infections.
Paul A. Tambyah;Kathleen T. Halvorson;Dennis G. Maki.
Mayo Clinic proceedings (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: